AI Article Synopsis
- The study focused on the relationship between microvesicles from dying endothelial cells and different types of chronic heart failure (HF).
- The research involved 388 HF patients, including those with reduced, preserved, and mid-range left ventricular ejection fractions.
- Key findings indicated that while some microvesicle markers were similar in certain HF patients, specific markers, especially CD144/annexin V MVs, were significantly higher in HFrEF patients and could enhance prediction capabilities for heart failure outcomes.
Article Abstract
: to evaluate the associations between signatures of apoptotic endothelial cell-derived microvesicles (MVs) with phenotypes of chronic heart failure (HF). The study cohort consisted of 388 prospectively involved subjects with HF patients with predominantly reduced left ventricular ejection fraction (HFrEF), HF with preserved ejection fraction (HFpEF) and HF with mid-range ejection fraction (HFmrEF). All biomarkers were measured at baseline. The number of circulating CD31/annexin V MVs in HFrEF and HFmrEF patients was similar. The number of circulating CD144/annexin V MVs in HFrEF patients was significantly higher than HFmrEF and HFpEF. We determined that a combination of number of circulating CD31/annexin V MVs and Gal-3 was the best predictor of HFpEF and that number of circulating CD144/annexin V MVs is able to increase predictive capabilities of soluble ST2 (sST2) and Gal-3 for HFrEF. We found that the number of circulating CD31/annexin V MVs may improve a predictive capacity for conventional HF biomarkers.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/bmm-2018-0449 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Stroke severity shapes extracellular vesicle profiles and their impact on the cerebral endothelial cells.
J Physiol
January 2025
Vascular Physiology Laboratory, Group of Research and Innovation in Vascular Health, Department of Basic Sciences, Faculty of Basic Sciences, Universidad del Bío-Bío, Chillán, Chile.
Ischaemic stroke is a leading cause of death and disability. Circulating extracellular vesicles (EVs) post-stroke may help brain endothelial cells (BECs) counter ischaemic injury. However data on how EVs from ischaemic stroke patients, considering injury severity, affect these cells are limited.
View Article and Find Full Text PDFSerially quantifying TERT rearrangement breakpoints in circulating tumor DNA enables minimal residual disease monitoring in patients with neuroblastoma.
Cancer Res Commun
January 2025
Charité, Berlin, Germany.
Telomerase is reactivated by genomic TERT rearrangements in ~30% of diagnosed high-risk neuroblastomas. Dismal patient prognosis results if the RAS/MAPK/ALK signaling transduction network also harbors mutations. We present a liquid biopsy-based monitoring strategy for this particularly vulnerable pediatric patient subgroup, for whom real-time molecular diagnostic tools are limited to date.
View Article and Find Full Text PDFPurpose: The aim of the current study was to evaluate changes in choroidal circulation hemodynamics after periocular skin warming at 40°C using laser speckle flowgraphy (LSFG).
Methods: Twenty-four right eyes of 24 healthy participants were included. Changes in choroidal circulation hemodynamics were determined using LSFG to evaluate the mean blur rate (MBR) of the macula, which represents choroidal blood flow velocity.
Endothelial progenitor cells as an angiogenic biomarker for the diagnosis and prognosis of lung cancer.
Rep Pract Oncol Radiother
December 2024
Radiobiology Laboratory, Department of Molecular Biology and Biotechnology, Atomic Energy Commission (AEC), Damascus, Syria.
Background: Angiogenesis is mediated by endothelial progenitor cells (EPCs) derived from bone-marrow. In this prospective study, we tried to investigate the clinical utility of circulating EPCs in lung cancer (LC) patients.
Materials And Methods: Flow cytometry technique was used to assess circulating EPCs according to the immuno-phenotype CD45 CD34 CD133 CD146 mononuclear cells.
The Impact on Patient Prognosis of Changes to the Method of Notifying Staff About Accepting Patients With Out-of-Hospital Cardiac Arrest.
J Clin Med Res
December 2024
Department of Surgery, Imamura Hospital, Tosu, Saga, Japan.
Background: Our hospital is a designated emergency hospital and accepts many patients with out-of-hospital cardiac arrest (OHCA). Previously, after receiving a direct call from emergency services to request acceptance of an OHCA patient, the emergency room (ER) chief nurse notified medical staff. However, this method delayed ER preparations, so a Code Blue system (CB) was introduced in which the pending arrival of an OHCA patient was broadcast throughout the hospital.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!